fbpx

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Category Archives for diagnostic testing

Multiple Myeloma Prognosis- Cytogenetic Prognostic Index

“The cytogenetic PI improves the classification of newly diagnosed patients with MM in the high-risk group compared with current classifications.” A multiple myeloma prognosis of a newly diagnosed

Continue reading

Myeloma Prognosis- Cytogenetics, Molecular Subtypes Explained

Multiple Myeloma survival (and prognosis) varies depending upon a host of factors: the stage of disease, biology including cytogenetic abnormalities and response to therapy. When it comes to a diagnosis

Continue reading

Multiple Myeloma Diagnostics- FISH, SPEP, CBC, FLC’s and Imaging

If you have multiple myeloma your plasma cells produce unhealthy antibodies called monoclonal proteins (M proteins). The accumulation of M proteins in your body can damage organs like your kidneys and

Continue reading

Bone Imaging Can Make or Break Multiple Myeloma

Bone imaging is a critical aspect of care for patients with multiple myeloma (MM), and recent advances in imaging modalities have improved detection of lytic lesions and bone marrow involvement. “Bone

Continue reading

Mammograms Identify Small Breast Cancers But do They Save Lives?

Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available. No matter

Continue reading

Multiple Myeloma Imaging- “MRI With Contrast” Gadolinium Spurs Myeloma?

“Gadolinium (Gd)-based contrast agents are frequently used to enhance MRI resolution. We evaluated effect of the most common Gd-containing agent, Omniscan, on myeloma cells.” Multiple myeloma

Continue reading

Multiple Myeloma Stem Cell Transplant? C-Reactive Protein, Heart, OS-

Elevated pre-ASCT C-Reactive Protein identifies a high-risk population especially in patients undergoing delayed ASCT for multiple myeloma… Myeloma patients can wait to have a stem cell transplant.

Continue reading

Multiple Myeloma and MRI- New Contrast Agent for MRI -Safer?

While the first (contrast agent for MRI) was approved by the U.S. Food and Drug Administration (FDA) in 1988, there are lingering safety concerns about these agents (especially for MM)… Multiple

Continue reading

MRD, Multiple Myeloma and Medicare

The first and only test authorized by the FDA to detect and monitor minimal residual disease (MRD) in multiple myeloma (MM)…has received coverage for Medicare patients. I am a multiple myeloma survivor

Continue reading

“Oh no, I’m MRD-positive!,” What do MM patients do if they are Positive not Negative?

“In the (MM) patients who have been treated with or without transplant but achieve MRD-negative status and CR , when they looked at their survival curves, they were very comparable, not statistically

Continue reading
1 2 3 7